Health
A SARS-CoV-2 neutralizing antibody with extensive spike binding coverage – News-Medical.Net
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe…
In a recently published research paper in the journal Nature Communications, a team of scientists from China has described the antiviral efficacy of a novel anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody isolated from recovered coronavirus disease 2019 (COVID-19) patients.
The structural and functional characterization of the antibody reveals that it covers most of the receptor-binding motif of the spike receptor-binding domain (RBD) and is highly potent in completely…
-
Business23 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News20 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
General7 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
Business20 hours ago1 ASX dividend stock down 43% I’d buy right now